The US Food and Drug Administration (FDA) has granted 510 (k) clearance for BlueWind Medical, Ltd.’s enhanced Revi® implantable tibial neuromodulator for treatment of urgency urinary incontinence (UUI ...
You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Riddhi Kanetkar Every time Riddhi publishes a story, you’ll get an alert straight to your inbox ...
Revi is the first iTNM device for the treatment of UUI labeled for use without prior failure of more conservative therapies, including medication. With concerns 3 about the potential link between ...
PARK CITY, Utah, April 9, 2024 /PRNewswire/ -- BlueWind Medical, Ltd., a trailblazer in patient-centric healthcare innovations, announced that distinguished urologist Dr. Jeffrey Carey of the Central ...
PARK CITY, Utah--(BUSINESS WIRE)--BlueWind Medical, Ltd., a leader in implantable Tibial NeuroModulation (iTNM) and the developer of the Revi® System, today announced that new two-year data from its ...
Environmental Lights, a leader in LED lighting solutions, announces the launch of their new REVI Remote-Voltage Illumination System. The REVI Remote-Voltage Illumination System is a comprehensive low ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback